Page 28 - Ipca Laboratories News Today

Ipca Laboratories (₹2,159): Buy Akhil Nallamuthu BL Research Bureau | Updated on April 15, 2021 × The stock of Ipca laboratories recently broke out of a consolidation range and the psychological hurdle at ₹2,000 which brought back the bullish momentum. Therefore, the stock seems to have aligned with the major uptrend and it is likely to appreciate further. The uptrend in the stock really began from about ₹400 levels in mid-2017 and has been gaining steadily since then. Interestingly, wh...

Suven Life Sciences Ltd, Cipla Ltd, Divis Laboratories Ltd and Ipca Laboratories Ltd are among the other gainers in the BSEs A group today, 12 April 2021. Suven Life Sciences Ltd, Cipla Ltd, Divis Laboratories Ltd and Ipca Laboratories Ltd are among the other gainers in the BSEs A group today, 12 April 2021. Solara Active Pharma Sciences Ltd soared 8.38% to Rs 1485.7 at 11:49 IST. The stock was the biggest gainer in the BSEs A group. On the BSE, 37497 shares were traded on the counter so far as...

CMP: ₹2,153.75 From our interaction with the management, we believe Ipca Laboratories (IPCA) has enough levers to outperform the market in Domestic Formulations (DF) and Branded Generics exports, with good visibility in the Institutional business and continued momentum in the API segment. IPCA has witnessed sustained growth momentum in the Pain segment. It has posted market share gains, on account of the pandemic, in products wherein smaller companies have been unable to meet supply requirem...

Read more about Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs on Business Standard. Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade

Ahead of Market: 12 things that will decide stock action on Wednesday SECTIONS Share Synopsis "We might see some consolidation in the index and it would be healthy. We thus advise using intermediate corrective moves to accumulate quality stocks on dips and avoid contrarian trades," said Ajit Mishra, VP - Research, Religare Broking. Getty Images Analysts said the 15,060-15,050 range is crucial and any breach of this zone may extend profit booking going ahead. Related NSE Explore Now NEW DELHI: ...

What big guys are buying and selling × Studying patterns in institutional holdings in a stock can be a starting point for your research Though the stock markets crashed in March last year, it soared to an all-time high by the end of December 2020. Institutional investors, both foreign and domestic, are big market drivers and most retail investors tend to take cues from the institutional investmentsfor their equity holdings. While this strategy may have a downside in terms of small investors e...

Story Share Market Highlights: Sensex ends above 50,600 for first time, Nifty at 14,895; ITC, SBI, M&M top gainers Dalal Street today: ITC, M&M, ONGC, Bajaj Finserv, NTPC were among the top gainers while ICICI Bank, IndusInd Bank, Infosys, HDFC traded as top losers BusinessToday.In | February 4, 2021 | Updated 16:07 IST Share Market News: Heres a look at the updates of the market action on BSE and NSE today Sensex, Nifty Highlights on February 4: Market indices rose sharply for the fourth stra...

Stocks in news: Airtel, Bajaj Consumer Care, Adani Transmission, Bandhan Bank, Hero MotoCorp Stocks to watch today on February 4: Airtel, Bajaj Consumer Care, Adani Transmission, Bandhan Bank, Hero MotoCorp among others are the top stocks to watch out for in Thursdays trading session BusinessToday.In | February 4, 2021 | Updated 09:43 IST Stocks to watch today: Sate Bank of India, Hero MotoCorp, Adani Power, Adani Transmission, Arvind, Bajaj Electricals are among the top companies that will be...

Explore Now NEW DELHI: Drug firm Ipca Laboratories on Thursday reported a 35.44 per cent rise in consolidated net profit to Rs 267.56 crore for the third quarter ended December 2020, on the back of robust sales in domestic and international markets. The company had posted a net profit of Rs 197.54 crore for the same period of the previous fiscal, Ipca Labs said in a BSE filing. Its consolidated total income stood at Rs 1,425.21 crore for the quarter under consideration. It was Rs 1,230.99 cror...

Volatility jumped to 25.34 levels at close on Friday, from 22.42 levels seen on previous Friday ahead of budget, due to selling pressure in emerging markets.